SYNERGISTIC COMBINATIONS OF RETINOID RECEPTOR LIGANDS AND SELECTED CYTOTOXIC AGENTS FOR TREATMENT OF CANCER.

• 1. 含有类维生素A受体配体和选择的细胞毒性剂的用于治疗癌症的协同联合体系 [P] . 中国专利： CN1498105A . 2004-05-19
• 2. 用于制备类视黄醇X受体-特异性类视黄醇的化合物和合成方法 [P] . 中国专利： CN111465402A . 2020-07-28
• 3. SYNERGISTIC COMBINATIONS OF RETINOID RECEPTOR LIGANDS AND SELECTED CYTOTOXIC AGENTS FOR TREATMENT OF CANCER [P] . PL368946A1 . 2005-04-04

  机译： 类视黄醇受体配体与某些细胞毒剂协同治疗肿瘤

• 4. SYNERGISTIC COMBINATIONS OF RETINOID RECEPTOR LIGANDS AND SELECTED CYTOTOXIC AGENTS FOR TREATMENT OF CANCER [P] . 欧洲知识产权局专利： EP1383491A2 . 2004-01-28

  机译： 类视黄醇受体配体与某些细胞毒剂协同治疗肿瘤

• 5. SYNERGISTIC COMBINATIONS OF RETINOID RECEPTOR LIGANDS AND SELECTED CYTOTOXIC AGENTS FOR TREATMENT OF CANCER [P] . HU0400255A2 . 2004-08-30

  机译： 类视黄醇受体配体与某些细胞毒剂协同治疗肿瘤

• 1. Radio-ligand receptor binding assay in vitro and animal biodistribution in vivo of 99Tcm-N-ethyl-N2S2-memantine as a potential NMDA receptor imaging agent [J] . LIU Yingtao, ZHOU Xingqin, CAO Guoxian, 核技术（英文版） . 2010,第003期
• 2. An innovative approach for the treatment of Alzheimer's disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions [J] . Luca Piemontese 中国神经再生研究（英文版） . 2019,第001期
• 3. Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival [J] . B. E. Cham 癌症治疗（英文） . 2020,第008期
• 4. Magnetic Microbead Affinity Selection Screening (MagMASS) for Retinoid X Receptor-α (RXRα) Ligands as Novel Anti-Inflammatory Agents [C] . Ruth N. Muchiri, Michael D. Rush, Elisabeth M. Walker, ASMS Conference on Mass Spectrometry and Allied Topics . 2016
• 5. Combinatorial targeting of the glucagon-like peptide-1 and sulfonylurea-1 receptors using a complimentary mulitvalent glucagon-like peptide-1/glibenclamide ligand for the improvement of beta-cell targeting agents and diabetic treatment. [D] . Hart, Nathaniel. 2013
• 6. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)- RAR beta- or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand. [O] . B Roy, R Taneja, P Chambon 1995
• 7. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand. [O] . Roy, B, Taneja, R, Chambon, P 1995
• 8. EgF Receptor Mabs and Chemotherapy/Characterization of Synergistic Interactions Between Cytotoxic Agents and Inhibitors of the Tyrosine Kinase Growth Factor Receptor Signalling Cascade [R] . Seidman, A. D. 1998

• 1. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents:Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells [J] . Khosit Pinmai ,Sriharut Chunlaratthanabhorn ,Chatri Ngamkitidechakul . 世界胃肠病学杂志：英文版 . 2008,第10期
• 2. Synergistic and attenuated effect of active protein P23 in combination treatment with docetaxel plus cisplatin in NSCLC SPC-A-1 tumor xenograft [J] . . 中国药理学通报 . 2015,第B11期
• 3. 中国北方汉族人群杀伤细胞免疫球蛋白样受体及其配体人类白细胞抗原-Ⅰ类分子基因多态性分布研究 [C] . 吴凌燕 ,谢正德 ,刘亚丽 . 中华医学会第十八次全国儿科学术会议 . 2013
• 4. 维甲酸受体激动剂他米巴罗汀协同粒细胞集落刺激因子治疗肿瘤化疗引起中性粒细胞缺乏症的作用及机制研究 [A] . 李琳 . 2016